Paper31969331
ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases.
Kumthekar P and 15 others. Clin Cancer Res, 2020. Cited by 207 papers, by iCite.
Cite this record
ConductScience Library. ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases. Papers, record 31969331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31969331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Breast Neoplasms | Major topic |
| Meningeal Carcinomatosis | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Paclitaxel | Major topic |
| Peptides | Major topic |
| Adult | |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Prognosis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30CA023074 | NIH |
Source NIH RePORTER
Cited by137
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42751312 | Boron-embedded multifunctional nanoplatform toward potential combined boron neutron capture therapy and immunomodulation in glioma. | Smart Mol | 2026 | https://conductscience.org/library/papers/42751312 | PubMed |
| 42744036 | Therapeutic potential of colchicine-binding site inhibitors in breast cancer brain metastasis. | Cancer Lett | 2026 | https://conductscience.org/library/papers/42744036 | PubMed |
| 42639267 | RNA-Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42639267 | PubMed |
| 42575968 | Protein-protein interaction-mediated signaling networks in ischemic stroke: from molecular mechanisms to therapeutic strategies. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42575968 | PubMed |
| 42559290 | Antibody-Drug Conjugates and Peptide-Drug Conjugates: Current Understandings and Future Perspectives. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42559290 | PubMed |
| 42395902 | Anti-SARS-CoV-2 VHH and C7C peptide fused with Angiopep-2 efficiently traverse blood-brain barrier model and neutralizes virus. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42395902 | PubMed |
| 42262659 | Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42262659 | PubMed |
| 42196473 | Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196473 | PubMed |
| 41938756 | HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/41938756 | PubMed |
| 41938171 | Blood-Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41938171 | PubMed |
| 41836468 | Peptides as multifunctional linchpins in targeted drug conjugates. | RSC Med Chem | 2026 | https://conductscience.org/library/papers/41836468 | PubMed |
| 41828617 | When 'Dirty' Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer Drugs. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828617 | PubMed |
| 41710577 | Tumor Targeting with Peptide-Drug Conjugates: Showcasing Key Progress and Hurdles. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41710577 | PubMed |
| 41660126 | Advancing precision tumor therapy: Progress in targeted delivery of peptide-based nanomaterials from microenvironment to organelles. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41660126 | PubMed |
| 41654916 | Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain. | Fluids Barriers CNS | 2026 | https://conductscience.org/library/papers/41654916 | PubMed |
| 41594569 | From Mechanism to Medicine: Peptide-Based Approaches for Cancer Diagnosis and Therapy. | Biomolecules | 2025 | https://conductscience.org/library/papers/41594569 | PubMed |
| 41425250 | Mechanisms of resistance to antibody-drug conjugates in cancer therapy: molecular basis and therapeutic strategies. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/41425250 | PubMed |
| 41345392 | Cancer cell-monocyte co-culture spheroids recapitulate pro-tumorigenic, immunosuppressive, and drug-resistant microenvironments in brain metastatic breast cancer. | NPJ Breast Cancer | 2025 | https://conductscience.org/library/papers/41345392 | PubMed |
| 41001098 | The Peptide-Drug Conjugate M1pep-Tasquinimod Ameliorates Acute Pancreatitis via Selectively Clearing M1-like Macrophages. | Biomater Res | 2025 | https://conductscience.org/library/papers/41001098 | PubMed |
| 40907474 | Novel approaches to clinical trial design in cancer neuroscience. | Neuron | 2025 | https://conductscience.org/library/papers/40907474 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LRP1 | 4035 | PubTator's text mining | https://conductscience.org/library/genes/4035 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31969331
GET https://conductscience.org/api/papers/v1/31969331/cited_by?page=2